The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: Direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells

J. J. Mule, J. Yang, S. Shu, S. A. Rosenberg

Research output: Contribution to journal › Article › peer-review

92 Scopus citations

Fingerprint

Dive into the research topics of 'The anti-tumor efficacy of lymphokine-activated killer cells and recombinant interleukin 2 in vivo: Direct correlation between reduction of established metastases and cytolytic activity of lymphokine-activated killer cells'. Together they form a unique fingerprint.

Medicine & Life Sciences